{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:55:28Z","timestamp":1794642928584,"version":"4.9.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Preservation of fertility has become a growing concern in young females with Hodgkin lymphoma (HL). However, the rate of pregnancy after the current most frequently prescribed ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, and darcarbazine) chemotherapy for HL has rarely been studied. In this study, we aim to determine the impact of ABVD on the fertility of women treated for HL. We conducted a noninterventional, multicenter study of female patients of childbearing age who were treated for HL. Two healthy apparied women nonexposed to chemotherapy (our controls) were assigned for each patient. Fertility was assessed by the number of pregnancies and births after HL treatment. Sixty-seven patients were included. The median age at diagnosis was 24.4 years (range, 16-43). HL was a localized disease for 68.7%. Of all the patients, 53.7% started at least 1 pregnancy after treatment vs 54.5% of the controls (P\u00a0= .92). Of all the patients who desired children, 81% had at least 1 pregnancy. Patients treated with ABVD did not have a longer median time to pregnancy (4.8 years in the group of patients and 6.8 years for controls). Across patients, there were 58 pregnancies and 48 births (ratio, 1:2) and 136 pregnancies and 104 births (ratio, 1:3) for the control cohort. No increase in obstetric or neonatal complications has been reported in HL in our study. The number of pregnancies, births, and the time to start a pregnancy in young women treated with ABVD for HL is not different from that of controls. Therefore, females with HL treated with ABVD should be reassured regarding fertility.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005557","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T17:09:38Z","timestamp":1663780178000},"page":"3978-3983","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine"],"prefix":"10.1182","volume":"7","author":[{"given":"Antoine","family":"Machet","sequence":"first","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Poudou","sequence":"additional","affiliation":[{"name":"2Department of Medically Assisted Procreation, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tomowiak","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gastinne","sequence":"additional","affiliation":[{"name":"3Department of Hematology, University Hospital of Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gardembas","sequence":"additional","affiliation":[{"name":"4Department of Hematology, University Hospital of Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Systchenko","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Moya","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Debiais","sequence":"additional","affiliation":[{"name":"5Department of Anatomopathology, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Levy","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Gruchet","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Sabirou","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Noel","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bouyer","sequence":"additional","affiliation":[{"name":"6Department of Cytology, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Delwail","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8755-5591","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Guidez","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Cell Therapy, University Hospital of Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"9844","key":"2023080717351762100_bib1","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","article-title":"Hodgkin\u2019s lymphoma in adults","volume":"380","author":"Townsend","year":"2012","journal-title":"Lancet"},{"key":"2023080717351762100_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bjh.15566","article-title":"Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom","volume":"184","author":"Br\u00f6ckelmann","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"2023080717351762100_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7","article-title":"Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP","volume":"36","author":"Bonadonna","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"2023080717351762100_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.2002.03564.x","article-title":"Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation","volume":"118","author":"Delwail","year":"2002","journal-title":"Br J Haematol"},{"issue":"4","key":"2023080717351762100_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/cncr.23247","article-title":"Twenty-year disease and treatment associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation","volume":"112","author":"S\u00e9n\u00e9cal","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"2023080717351762100_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.802","article-title":"Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy","volume":"25","author":"Hodgson","year":"2007","journal-title":"Hematol Oncol"},{"issue":"2","key":"2023080717351762100_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-M\u00fcllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary. Anti-M\u00fcllerian hormone follow-up results","volume":"20","author":"Decanter","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"30","key":"2023080717351762100_bib8","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","article-title":"Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group","volume":"23","author":"Behringer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"2023080717351762100_bib9","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-06-1420","article-title":"Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin\u2019s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up","volume":"12","author":"Brusamolino","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023080717351762100_bib10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.bjc.6603711","article-title":"Post-treatment parenthood in Hodgkin\u2019s lymphoma survivors","volume":"96","author":"Kiserud","year":"2007","journal-title":"Br J Cancer"},{"issue":"3","key":"2023080717351762100_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10815-015-0636-6","article-title":"Fertility in young patients following treatment for Hodgkin\u2019s lymphoma: a single center survey","volume":"33","author":"Bolte\u017ear","year":"2016","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"2","key":"2023080717351762100_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"2023080717351762100_bib13","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2011.40.8906","article-title":"Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study","volume":"30","author":"Van der Kaaij","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"2023080717351762100_bib14","first-page":"2100357","article-title":"Parenthood rates and use of assisted reproductive technique in younger Hodgkin lymphoma survivors: a Danish population-based study","author":"\u00d8vlisen","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"2023080717351762100_bib15","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3324\/haematol.2011.045856","article-title":"Management of fertility in patients treated for Hodgkin's lymphoma","volume":"96","author":"Harel","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"2023080717351762100_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/fon-2016-0441","article-title":"Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations","volume":"13","author":"Poirot","year":"2017","journal-title":"Future Oncol"},{"issue":"3","key":"2023080717351762100_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1200\/JCO.2011.37.1989","article-title":"Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study","volume":"30","author":"Van der Kaaij","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"2023080717351762100_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz284","article-title":"Preserving fertility in female patients with hematological malignancies, a multidisciplinary oncofertility approach","author":"Salama","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"2023080717351762100_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2010.07.009","article-title":"Pregnancy after hematopoietic cell transplantation: a report of the late effects working committee of the Center for International Blood and Marrow Transplantation Research (CIBMTR)","volume":"17","author":"Loren","year":"2011","journal-title":"Biol Bone Marrow Transplant"},{"issue":"4","key":"2023080717351762100_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjh.12651","article-title":"Fertility and sexual function in long-term survivors of haematological malignancy: using patient-reported outcome measures to assess a neglected area of need in the late effects clinic","volume":"164","author":"Greaves","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"2023080717351762100_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2008-1073143","article-title":"Having children after surviving cancer in childhood or adolescence---results of a Berlin survey","volume":"220","author":"Reinmuth","year":"2008","journal-title":"Klin P\u00e4diatr"},{"issue":"3","key":"2023080717351762100_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pon.1714","article-title":"Barriers to procreational intentions among cancer survivors 2 years after diagnosis: a French national cross-sectional survey","volume":"220","author":"Mancini","year":"2011","journal-title":"Psycho Oncol"},{"issue":"3","key":"2023080717351762100_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1200\/JCO.2007.15.3130","article-title":"Reproduction rates after cancer treatment: experience from the Norwegian Radium Hospital","volume":"27","author":"Cvancarova","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"2023080717351762100_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jncimonographs\/lgi017","article-title":"Defining and measuring reproductive concerns of female cancer survivors","volume":"34","author":"Wenzel","year":"2005","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"issue":"5","key":"2023080717351762100_bib25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3324\/haematol.2010.036129","article-title":"Italian Association of Pediatric Hematology and Oncology (AIEOP) Group. Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry","volume":"96","author":"Pivetta","year":"2011","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3978\/2069614\/blooda_adv-2021-005557-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3978\/2069614\/blooda_adv-2021-005557-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T17:35:42Z","timestamp":1691429742000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/3978\/486669\/Hodgkin-lymphoma-and-female-fertility-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":25,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005557","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}